Literature DB >> 32495126

Pre-operative Microvascular Invasion Prediction Using Multi-parametric Liver MRI Radiomics.

Giacomo Nebbia1, Qian Zhang2, Dooman Arefan3, Xinxiang Zhao4, Shandong Wu5,6,7,8.   

Abstract

Microvascular invasion (mVI) is the most significant independent predictor of recurrence for hepatocellular carcinoma (HCC), but its pre-operative assessment is challenging. In this study, we investigate the use of multi-parametric MRI radiomics to predict mVI status before surgery. We retrospectively collected pre-operative multi-parametric liver MRI scans for 99 patients who were diagnosed with HCC. These patients received surgery and pathology-confirmed diagnosis of mVI. We extracted radiomics features from manually segmented HCC regions and built machine learning classifiers to predict mVI status. We compared the performance of such classifiers when built on five MRI sequences used both individually and combined. We investigated the effects of using features extracted from the tumor region only, the peritumoral marginal region only, and the combination of the two. We used the area under the receiver operating characteristic curve (AUC) and accuracy as performance metrics. By combining features extracted from multiple MRI sequences, AUCs are 86.69%, 84.62%, and 84.19% when features are extracted from the tumor only, the peritumoral region only, and the combination of the two, respectively. For tumor-extracted features, the T2 sequence (AUC = 80.84%) and portal venous sequence (AUC = 79.22%) outperform other MRI sequences in single-sequence-based models and their combination yields the highest AUC of 86.69% for mVI status prediction. Our results show promise in predicting mVI from pre-operative liver MRI scans and indicate that information from multi-parametric MRI sequences is complementary in identifying mVI.

Entities:  

Keywords:  Hepatocellular carcinoma; MRI; Machine learning; Microvascular invasion; Radiomics

Mesh:

Year:  2020        PMID: 32495126      PMCID: PMC7728938          DOI: 10.1007/s10278-020-00353-x

Source DB:  PubMed          Journal:  J Digit Imaging        ISSN: 0897-1889            Impact factor:   4.056


  26 in total

1.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

Review 2.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

3.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

4.  Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story.

Authors:  Karim J Halazun; Marc Najjar; Rita M Abdelmessih; Benjamin Samstein; Adam D Griesemer; James V Guarrera; Tomoaki Kato; Elizabeth C Verna; Jean C Emond; Robert S Brown
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

5.  Recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  A Escartin; G Sapisochin; I Bilbao; R Vilallonga; J Bueno; L Castells; C Dopazo; E Castro; M Caralt; J Balsells
Journal:  Transplant Proc       Date:  2007-09       Impact factor: 1.066

6.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Authors:  Sean F Altekruse; Katherine A McGlynn; Marsha E Reichman
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

7.  Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis.

Authors:  Parissa Tabrizian; Ghalib Jibara; Brian Shrager; Myron Schwartz; Sasan Roayaie
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

8.  Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.

Authors:  Jessica L Petrick; Scott P Kelly; Sean F Altekruse; Katherine A McGlynn; Philip S Rosenberg
Journal:  J Clin Oncol       Date:  2016-04-04       Impact factor: 44.544

9.  Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.

Authors:  T F Greten; F Papendorf; J S Bleck; T Kirchhoff; T Wohlberedt; S Kubicka; J Klempnauer; M Galanski; M P Manns
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

10.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

View more
  14 in total

1.  Automatic discrimination of different sequences and phases of liver MRI using a dense feature fusion neural network: a preliminary study.

Authors:  Shu-Hui Wang; Jing Du; Hui Xu; Dawei Yang; Yuxiang Ye; Yinan Chen; Yajing Zhu; Te Ba; Chunwang Yuan; Zheng-Han Yang
Journal:  Abdom Radiol (NY)       Date:  2021-05-31

2.  Preoperative Prediction of Microvascular Invasion Risk Grades in Hepatocellular Carcinoma Based on Tumor and Peritumor Dual-Region Radiomics Signatures.

Authors:  Fang Hu; Yuhan Zhang; Man Li; Chen Liu; Handan Zhang; Xiaoming Li; Sanyuan Liu; Xiaofei Hu; Jian Wang
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

3.  MVI-Mind: A Novel Deep-Learning Strategy Using Computed Tomography (CT)-Based Radiomics for End-to-End High Efficiency Prediction of Microvascular Invasion in Hepatocellular Carcinoma.

Authors:  Liyang Wang; Meilong Wu; Rui Li; Xiaolei Xu; Chengzhan Zhu; Xiaobin Feng
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

4.  Radiomics models for preoperative prediction of microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Xian Zhong; Haiyi Long; Liya Su; Ruiying Zheng; Wei Wang; Yu Duan; Hangtong Hu; Manxia Lin; Xiaoyan Xie
Journal:  Abdom Radiol (NY)       Date:  2022-04-01

5.  Arterial Spin Labeling MRI for Predicting Microvascular Invasion of T1 Staging Renal Clear Cell Carcinoma Preoperatively.

Authors:  Han-Mei Zhang; Da-Guang Wen; Yi Wang; Yi-Ge Bao; Yuan Yuan; Yun-Tian Chen; Bin Song
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

6.  Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Multi-Parametric MRI Radiomics.

Authors:  Yang Zhang; Zhenyu Shu; Qin Ye; Junfa Chen; Jianguo Zhong; Hongyang Jiang; Cuiyun Wu; Taihen Yu; Peipei Pang; Tianshi Ma; Chunmiao Lin
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

7.  Prediction of Microvascular Invasion in Hepatocellular Carcinoma With a Multi-Disciplinary Team-Like Radiomics Fusion Model on Dynamic Contrast-Enhanced Computed Tomography.

Authors:  Wanli Zhang; Ruimeng Yang; Fangrong Liang; Guoshun Liu; Amei Chen; Hongzhen Wu; Shengsheng Lai; Wenshuang Ding; Xinhua Wei; Xin Zhen; Xinqing Jiang
Journal:  Front Oncol       Date:  2021-03-16       Impact factor: 6.244

Review 8.  Progress of MRI Radiomics in Hepatocellular Carcinoma.

Authors:  Xue-Qin Gong; Yun-Yun Tao; Yao-Kun Wu; Ning Liu; Xi Yu; Ran Wang; Jing Zheng; Nian Liu; Xiao-Hua Huang; Jing-Dong Li; Gang Yang; Xiao-Qin Wei; Lin Yang; Xiao-Ming Zhang
Journal:  Front Oncol       Date:  2021-09-20       Impact factor: 6.244

9.  Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma.

Authors:  Yan Yang; WeiJie Fan; Tao Gu; Li Yu; HaiLing Chen; YangFan Lv; Huan Liu; GuangXian Wang; Dong Zhang
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

10.  Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy.

Authors:  Huanhuan Chong; Yuda Gong; Xianpan Pan; Aie Liu; Lei Chen; Chun Yang; Mengsu Zeng
Journal:  J Hepatocell Carcinoma       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.